The International Society of Microbiota is pleased to welcome Biocrates Life Sciences AG to the 7th Targeting Microbiota World Congress 2019 !

Biocrates Life Sciences AG, internationally renowned developer of targeted metabolic phenotyping solutions, supports the discovery and validation of biomarkers for complex multifactorial diseases in pre-clinical and clinical research.

Based in Innsbruck and with a subsidiary in the US, the company provides user friendly and ready to measure kits for quantitative, mass spectrometry based metabolite analysis.

Biocrates MxP Quant 500 Kit allows standardized measurement of up to 630 metabolites, many of which are associated with microbial metabolism (such as secondary bile acids).

This enables researchers to unravel the functional relationship between host, nutrition and the microbiome.

DNA Genotek received the ISM Industrial Award during Targeting Microbiota 2019

International Society of Microbiota (ISM) is honored to announce DNA Genotek as one of three winners of the Industrial Innovation Awards, during the 7th World Congress on Targeting Microbiota 2019, which was held in Krakow, Poland.

DNA Genotek is recognized as a leader worldwide in the production and development of standardized skin microbiome and fecal metabolomics collection methodologies.

Testimonial by Heloise Breton, from DNA Genotek:
"We would like to thank the scientific committee for awarding us the the industrial innovation award. As a company dedicated to developing products to optimize ease of collection and provide superior samples and proven performance, we are so happy to see our value in the industry recognized. This year’s Targeting Microbiota conference consisted of many great talks that captured the role of the microbiome in human and animal systems. The connection between the brain and the gut is a huge development and the work happening in this field will be life changing for neurological diseases such as Alzheimer’s. Skin microbiome is an upcoming topic and of high interest for us as we have been working on a collection device for skin sampling which will launch soon. This is a topic that has many applications as seen in the talks regarding cosmetics, immune function and cutaneous homeostasis. There is so much amazing research happening in Europe and we enjoy being a part of such an innovative scientific community. We hope to see the ISM grow every year and to continue to provide a platform for the future of microbiome research."

Media center: 
Internternational Society of Microbiota
Contact: [email protected]
www.microbiota-site.com

Microbiota and Autism: Recent Advances and Perspectives

Dr. Tatjana Mijatovic from R.E.D. Laboratories, Belgium, one of our sponsor, will join the 7th World congress on Targeting Microbiota 2019 Congress and give a key presentation entitled "Biomedical approach in autism spectrum disorders – the importance of assessing inflammation".

The Impact of Lactobacillus, Bifidobacterium, E.Coli and Lactoferrin on the Phenomenon of Translocation in the Low-Birth-Weight Preterm Neonates

During the congress, Prof. Magdalena Strus from Jagiellonian University Medical College, Poland will give presentation entitled "The Impact of Lactobacillus, Bifidobacterium, E.Coli and Lactoferrin on the Phenomenon of Translocation in the Low-Birth-Weight Preterm Neonates".

For more information: www.microbiota-site.com

International Society of Microbiota awarded R.E.D. Laboratories during Targeting Microbiota 2019

International Society of Microbiota (ISM) is honored to discern Industrial Innovation Award to R.E.D. Laboratories during the 7th World Congress on Targeting Microbiota 2019, which was held in Krakow, Poland.

R.E.D. Laboratories highlighted the high importance of assessing inflammation-related markers in the evaluation of autism spectrum disorders-diagnosed patients.

Testimonial by Dr. Tanja Mijatovic, from R.E.D. Laboratories:
"I really enjoyed the Conference, it was all very well organized and extremely professional.  A great conference to attend for anyone in the microbiome fields. Great for gaining insights into unpublished research and clinical findings, and a significant opportunity to network with enthusiastic colleagues. I came back with valuable insights and fully charged with positive emotions. Huge thanks to the organizers. It was amazing to be awarded. Looking forward to be back next year."

Media center: 
International Society of Microbiota 
Contact: [email protected]
www.microbiota-site.com

Intergenerational Transfer of the Atopic-Disease Potential from the Murine Maternal Gut Microbiota Grafted with Human Faecalibacterium Prausnitzii Pathobionts

Prof. Heenam Stanley Kim from Korea University, Korea will join again the Targeting Microbiota 2019 Congress and present his work "Intergenerational Transfer of the Atopic-Disease Potential from the Murine Maternal Gut Microbiota Grafted with Human Faecalibacterium Prausnitzii Pathobionts" during the congress.

For more information: www.microbiota-site.com

Skin-Bacterial Microbiota Communication: A new element in cutaneous neurogenic inflammation

Dr. Marc G.J. Feuilloley from University of Rouen Normandy, France will talk about "Skin-Bacterial Microbiota Communication: A new elment in cutaneous neurogenic inflammation" during the 7th World Congress on Targeting Microbiota scheduled on October 10-11, 2019 at the Park Inn Hotel - Krakow, Poland. 

Dr. Feuilloley will talk during Session "Skin microbiota 2019: From basics to applied cosmetics and skin care" and among the speakers:

Dialogue between the skin and the microbiota: The immune system is under control
Chantal Pichon, French National Centre for Scientific Research, France

Intergenerational Transfer of the Atopic-Disease Potential from the Murine Maternal Gut Microbiota Grafted with Human Faecalibacterium Prausnitzii Pathobionts
Heenam Stanley Kim, Korea University, Korea

Intestinal barrier, gut microbiota and psoriasis
Mariusz Sikora, Medical University of Warsaw, Poland

For more information: www.microbiota-site.com

Fecal preservation by freeze-drying: applications and perspectives

Dr. Julie Reygner from Université Paris Descartes - Faculté de Pharmacie, France will join in the Congress and will present her work entitled "Fecal preservation by freeze-drying: applications and perspectives" during the congress.

Short summary: Fecal microbiota transplantation (FMT) has now evolved into an efficient therapeutic for the management of recurrent Clostridium difficile infections (rCDIs) with an efficient cure rate reaching 85-95%. We have previously shown that a freeze-dried formulation allowed to conserve FMT preparation over 12 months improving standardization of the stool preparation procedures, process time and thus facilitating patient access to this treatment. The new goal is to improve of the selection of donors, beyond safety of stool samples, in order to develop a rational selection of FMT donor according to the pathology to be treated.

Dr. Reygner is also Best Shor oral presentation award winner of last year and presented short oral presentation "A new freeze-dried formulation to conserve stools over 12 months for fecal transplantation".

This year, Dr. Reygner join participate as Major speaker and will elobrate more about her study on Fecal preservation, ecal transplantation.

For more information: www.microbiota-site.com

Industrial Innovation Award was discerned to Sethic Innovation Lab during Targeting Microbiota 2019

The Industrial Innovation Award was discerned to Sethic Innovation Lab during Targeting Microbiota 2019 Congress.

Scientific Committee awarded Sethic Innovation Lab for their innovating cosmetic ingredient OPTIMEALTH^(R), presented as a potent ingredient to prevents and reduce skin infections, inflammation and related disorders such as atopic dermatitis, rosacea, psoriasis, and acne.

Media center: 
International Society of Microbiota
Contact: [email protected]
www.microbiota-site.com

Microbiota Dysbiosis is Associated with HPV-Induced Cervical Carcinogenesis

Dr. Wojciech Kwaśniewski will present the findings of the present study on "Microbiota Dysbiosis is Associated with HPV-Induced Cervical Carcinogenesis". 

Short summary of the talk: "Over the last decade, it has been indicated that the development and introduction of molecular-based technology has provided novel information regarding the composition of the vaginal‐cervical flora, as well as the abnormal colonization of the genital tract by pathogens. It has been reported that microbe‐induced inflammation can contribute to cervical cancer by stimulating the production of specific cytokines and chemokines, which promote proliferation and/or inhibit apoptosis. Microbiota have been demonstrated to increase, as well as decrease susceptibility to HPV infection. The findings of the present study demonstrated a possible interaction between bacterial flora and HPV infection, as well as an association between this interaction and clinical cervical neoplasia."

For more information: www.microbiota-site.com

Dialogue between the skin and the microbiota: The immune system is under control

Dr. Chantal Pichon from French National Centre for Scientific Research (CNRS ), France will join the Targeting Microbiota 2019 Congress and present her research work on interaction between Skin and Microbiota during the presentation entitled “Dialogue between the skin and the microbiota: The immune system is under control“.

For more information: www.microbiota-site.com

Microbiota and cancer : between Detection and Prognosis

Dr. Romain Villeger from the University of Clermont Auvergne, France will give a presentation entitled "Microbiota and cancer : between Detection and Prognosis" during the 7th World Congress on Targeting Microbiota scheduled on October 10-11, 2019 at the ParkInn Hotel - Krakow, Poland.

The Scientific comittee asked Dr Villeger to comment the recent paper publish in sciencemag.org in July 05, 2019 concerning Microbial stages of colorectal cancer.

For more information: www.microbiota-site.com

Submit your questions before September 15, 2019 and WIN…

Despite the wealth of data typically presented, many questions of the participants remain unanswered, and for many scientists, even those who have been considered as keynote speakers, there is only limited opportunity to interact with colleagues.

To facilitate the scientific discussion and make the conference more interactive, the scientific committee has decided to include a round table discussions that address hot topics, challenges and pressing questions to various areas of Microbiota medicine and research.

All questions will be answered and the most pertinent and critical questions will be awarded with the free registration at the Next Microbiota 2020.

All participants are invited to participate in these discussions by sending their questions and thoughts before the meeting by the September 15, 2019 to microbiota(at)microbiota-site.com

Venue & Hotel Booking

Park Inn Hotel Krakow

Ul. Monte Cassino 2 PL-30337 - Krakow - Poland

Book your room here

Single Room: 115€ by night / Double Room: 125€ by night

Please note that due the limited number of rooms,  we have few negotiated rooms from 9th October to 11 October for 2 nights.

Special Rate for Room Booking at Park Inn by Radisson Krakow

Situated close to the area of tourist attractions, Park Inn By Radisson Krakow features views of Krakow, the Wawel Royal Castle and the Kosciuszko Mound. There is also a brief car trip from the Ogrody Krolewskie na Wawelu and Wawel Cathedral. Targeting Microbiota 2019 Committee offers to the congress attendees a special privileged rate for your booking: Single Room: 115€ by night Double Room: 125€ by night (If you would like to see price for DBL room you have to select 2 person on left side of reservation panel and click search.)   These prices include breakfast buffet, Wi-Fi connection and a free access to their modern fitness area.
Online Hotel Booking Promotional Code: MICROB
Terms & conditions: All room reservations during the Targeting Microbiota 2019 congress - October 10 - 11, 2019 will be made via dedicated booking link. This link will transfer you to Hotel website, where your reservation should be completed by you. You will have to guarantee the reservation by credit card. Credit card will be fully charged 14 days prior to your arrival. After this date no free cancelation will be possible and all reservations will be fully charged – 115 EUR/night (SGL room) or 125 EUR/night (DBL room). Paid reservation will be kept till 7.00 a.m. next hotel day. Room prices are valid from Oct 10, 2019 till Oct 12, 2019.

Psychotropic Drugs and Microbiota - Important and Little Known Interaction

During the 7th World Congress on Targeting Microbiota scheduled on October 10-11, 2019 at the ParkInn Hotel - Krakow, Poland, Dr. Igor Loniewski from Pomeranian Medical University, Poland will give a presentation entitled "Psychotropic Drugs and Microbiota - Important and Little Known Interaction".

Summary of presentation: "Alterations in intestinal microbiota have been associated with the use of antidepressants. Antidepressants differ in mechanisms of their antibacterial activity; for example, they affect cellular respiration, whereby Monoamine Oxidase Inhibitors (MAOIs) can disturb bacterial cell-wall synthesis. Tricyclic antidepressants (TCAs) inhibit DNA gyrase activity and plasmid DNA replication. Selective serotonin reuptake inhibitors (SSRIs) inhibit bacterial efflux pumps. Escitalopram has also antibacterial activity, moreover it was also shown that a six-week escitalopram treatment in a psychiatric hospital setting resulted in increased alpha biodiversity in fecal microbiota Antipsychotic treatment-related microbiome alterations potentially result in body weight gain and metabolic disturbances. Inflammation and resting metabolic rate suppression seem to play crucial roles in the development of metabolic disorders. However in our study we found that the microbiota of schizophrenia patients is highly individual but can be divided into different taxonomical and functional clusters and it does not change following six weeks of olanzapine therapy. Microbiota did not affect either the weight gain observed in women or the effectiveness of olanzapine therapy."

Skin microbiota 2019: From basics to applied cosmetics and skin care

Dr. Florence Abdallah from University Paris-Sud - Inserm, France will chair the session dedicated to Skin and Microbiota.

This session is made up of two parts that aim at outlining major findings of skin microbiota and highlighting the importance of skin microbiota modulation for cosmetic application.

The first part
Skin Microbiota : Recent advances and perspectives

This part consists on giving a general overview of the literature for major understandings of skin microbiota including main findings on microbial community composition and plasticity, the crosstalk with skin immune system in health and disease and the current available tools to study skin microbiome diversity.

The second part
Strategies to modulate and affect skin microbiota in health and diseases?

This part  is dedicated to the different possible mechanisms to modify skin microbiota. Since the microbiota is the era of new revolution for the cosmetics and skin care, various cosmetic products composed of probiotics or prebiotics will be presented and discussed.

Finally, an open discussion, questions marks and perspectives in skin microbiology research in health and in disease, and to promote beauty.

Among other speakers:

Dialogue between the skin and the microbiota: The immune system is under control
Chantal Pichon, French National Centre for Scientific Research, France

Intestinal barrier, gut microbiota and psoriasis
Mariusz Sikora, Medical University of Warsaw, Poland

Carcinogenic microbiota of oral cavity

Prof. Tomasz M. Karpiński, Head of Department of Medical Microbiology of Poznań University of Medical Sciences, Poland will join the Targeting Microbiota 2019 congress and will talk "Carcinogenic microbiota of oral cavity".  

Summary of presentation: "The most known bacterial carcinogen is Helicobacter pylori. Recent research indicates a role of oral microorganisms in cancer development. With oral cancer strongly correlate periopathogens, such as Peptostreptococcus sp., Prevotella sp., Fusobacterium sp., Porphyromonas gingivalis, and Capnocytophaga gingivalis. Many works have also shown that the Fusobacterium nucleatum and Porphyromonas gingivalis play an important role in the development of colorectal and pancreatic cancer. Three mechanisms of action have been suggested in the pathogenesis of cancer by oral microbiota: 1. bacterial stimulation of chronic inflammation, 2. influence on cell proliferation, and 3. production of carcinogenic substances".

For more information: www.microbiota-site.com

Gut bacterial metabolites as markers and mediators of cardiovascular aging

Prof. Marcin Ufnal will present a research work entitled "Gut bacterial metabolites as markers and mediators of cardiovascular aging".

The Scientific committee invited Prof. Marcin Ufnal from the Medical University of Warsaw, Poland to give a talk during the  7th World Congress on Targeting Microbiota.

Age is a risk factor of cardiovascular and metabolic diseases. Our study in rats suggests that age affects gut bacteria composition and increases concentration of several bacterial metabolites in blood plasma.

Prof. Ufnal will discuss our findings showing the mechanisms of such increase as well as biological effects of some of the bacterial metabolites.

For more information: www.microbiota-site.com

Modulating the microbiota of the hospital environment by probiotic cleaning: impact on infections and antimicrobial resistance

During the 7th World Congress on Targeting Microbiota scheduled on October 10-11, 2019 at the ParkInn Hotel - Krakow, Poland, the Scientific commitee will dedicate a full session related to the Built Environment Microbiome.

Dr. Elisabetta Caselli from the University of Ferrara, Italy will give a presentation entitled "Modulating the microbiota of the hospital environment by probiotic cleaning: impact on infections and antimicrobial resistance".

Dr. Caselli summarizes: "Healthcare–associated infections (HAIs) are a global concern, whose major causes include the persistent microbial contamination of the hospital environment, and the growing antimicrobial-resistance (AMR) of HAI-associated microbes.

The control of contamination has been so far addressed by the use of chemical-based sanitation procedures, which however do not prevent recontamination and can select resistant microbes.

By contrast, a microbial-based sanitation system, inspired by the microbiome balance principles, was shown to induce remodulation of hospital microbiota, obtaining a stable control of bioburden and AMR, associated to a significant reduction of HAIs."

International Space Station and hospital environments: Composition and function of microbiomes in confined built environments

During the 7th World Congress on Targeting Microbiota scheduled on October 10-11, 2019 at the Park Inn Hotel - Krakow, Poland, the Scientific commitee will dedicate a full session related to the Built Environment Microbiome.